SignificantEconomyBloomberg·US Trade Representative
US Starts Section 301 Probe of Germany Over Pharmaceuticals
The US Trade Representative launched a Section 301 probe into Germany concerning alleged underpayment for innovative pharmaceutical products. This action signals potential retaliatory tariffs on German goods.
Impact Score
7/10
Thursday, June 18, 2026 at 08:33 PM EDT
Read original source →